Kevin E. Weddington

Array ( [id] => 3808606 [patent_doc_number] => 05854272 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => '2-alkylpyrrolidines' [patent_app_type] => 1 [patent_app_number] => 8/892660 [patent_app_country] => US [patent_app_date] => 1997-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7758 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854272.pdf [firstpage_image] =>[orig_patent_app_number] => 892660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937531 [patent_doc_number] => 05972924 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Treatment of cerebral ischemia and cerebral damage with neuroprotective agents' [patent_app_type] => 1 [patent_app_number] => 8/860898 [patent_app_country] => US [patent_app_date] => 1997-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5103 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972924.pdf [firstpage_image] =>[orig_patent_app_number] => 860898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3762332 [patent_doc_number] => 05843998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Skin blemish treatment' [patent_app_type] => 1 [patent_app_number] => 8/884801 [patent_app_country] => US [patent_app_date] => 1997-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2294 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843998.pdf [firstpage_image] =>[orig_patent_app_number] => 884801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3886252 [patent_doc_number] => 05776930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Pharmaceutical preparation' [patent_app_type] => 1 [patent_app_number] => 8/881399 [patent_app_country] => US [patent_app_date] => 1997-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35549 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776930.pdf [firstpage_image] =>[orig_patent_app_number] => 881399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933861 [patent_doc_number] => 05929055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Therapeutic method for management of diabetes mellitus' [patent_app_type] => 1 [patent_app_number] => 8/880945 [patent_app_country] => US [patent_app_date] => 1997-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8149 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929055.pdf [firstpage_image] =>[orig_patent_app_number] => 880945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3838299 [patent_doc_number] => 05846971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Oral antifungal composition' [patent_app_type] => 1 [patent_app_number] => 8/879928 [patent_app_country] => US [patent_app_date] => 1997-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3493 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846971.pdf [firstpage_image] =>[orig_patent_app_number] => 879928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3980440 [patent_doc_number] => 05948810 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Use of R-(+)-.alpha.-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae' [patent_app_type] => 1 [patent_app_number] => 8/878843 [patent_app_country] => US [patent_app_date] => 1997-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3390 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948810.pdf [firstpage_image] =>[orig_patent_app_number] => 878843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314650 [patent_doc_number] => 06185453 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Iontophoretic delivery of integrin inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/877829 [patent_app_country] => US [patent_app_date] => 1997-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22242 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3442 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/185/06185453.pdf [firstpage_image] =>[orig_patent_app_number] => 877829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3967366 [patent_doc_number] => 05886040 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Creatine pyruvate salt with enhanced palatability' [patent_app_type] => 1 [patent_app_number] => 8/877612 [patent_app_country] => US [patent_app_date] => 1997-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4044 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886040.pdf [firstpage_image] =>[orig_patent_app_number] => 877612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4036726 [patent_doc_number] => 05856356 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Use of strontium salts and pharmaceutical compositions thereof for the treatment of arthrosis' [patent_app_type] => 1 [patent_app_number] => 8/873117 [patent_app_country] => US [patent_app_date] => 1997-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3084 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856356.pdf [firstpage_image] =>[orig_patent_app_number] => 873117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3944152 [patent_doc_number] => 05955103 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Dosage form comprising antiepileptic drug' [patent_app_type] => 1 [patent_app_number] => 8/871748 [patent_app_country] => US [patent_app_date] => 1997-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 10017 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955103.pdf [firstpage_image] =>[orig_patent_app_number] => 871748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3921287 [patent_doc_number] => 05876750 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Effective therapy for epilepsies' [patent_app_type] => 1 [patent_app_number] => 8/871075 [patent_app_country] => US [patent_app_date] => 1997-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 10005 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876750.pdf [firstpage_image] =>[orig_patent_app_number] => 871075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4193664 [patent_doc_number] => 06043283 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Tyramine compounds and their neuronal effects' [patent_app_type] => 1 [patent_app_number] => 8/870967 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 98 [patent_no_of_words] => 26209 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043283.pdf [firstpage_image] =>[orig_patent_app_number] => 870967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833423 [patent_doc_number] => 05814623 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides' [patent_app_type] => 1 [patent_app_number] => 8/863961 [patent_app_country] => US [patent_app_date] => 1997-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4762 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814623.pdf [firstpage_image] =>[orig_patent_app_number] => 863961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975261 [patent_doc_number] => 05958379 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => 1 [patent_app_number] => 8/809384 [patent_app_country] => US [patent_app_date] => 1997-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7919 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958379.pdf [firstpage_image] =>[orig_patent_app_number] => 809384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770362 [patent_doc_number] => 05849728 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Desquamation compositions' [patent_app_type] => 1 [patent_app_number] => 8/855900 [patent_app_country] => US [patent_app_date] => 1997-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6339 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849728.pdf [firstpage_image] =>[orig_patent_app_number] => 855900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4022838 [patent_doc_number] => 05925634 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Use of ibogaine for treating neuropathic pain' [patent_app_type] => 1 [patent_app_number] => 8/854979 [patent_app_country] => US [patent_app_date] => 1997-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10798 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925634.pdf [firstpage_image] =>[orig_patent_app_number] => 854979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009983 [patent_doc_number] => 05962445 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Treatment of asthma and airway diseases' [patent_app_type] => 1 [patent_app_number] => 8/853528 [patent_app_country] => US [patent_app_date] => 1997-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10454 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962445.pdf [firstpage_image] =>[orig_patent_app_number] => 853528 [rel_patent_id] =>[rel_patent_doc_number] =>)